GLA and Nager acrofacial dysostosis: In a mouse model of AFD, treatment with Moss-aGal led to similar distribution in the heart and spleen compared to agalsidase-alfa treated mice, with better distribution in the kidney, and similar efficacy for reduction in Gb3 (142).